Evidence map›Paper›PMID 35323406›Full record

ReviewBiosensors2022

Recent Advances of Point-of-Care Devices Integrated with Molecularly Imprinted Polymers-Based Biosensors: From Biomolecule Sensing Design to Intraoral Fluid Testing.

Rowoon Park, Sangheon Jeon, Jeonghwa Jeong, Shin-Young Park, Dong-Wook Han, Suck Won Hong

Abstract readReview
In one paragraph

Review in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rowoon ParkDepartment of Cogno-Mechatronics Engineering, Pusan National University, Busan 46241, Korea.
Sangheon JeonDepartment of Cogno-Mechatronics Engineering, Pusan National University, Busan 46241, Korea.
Jeonghwa JeongDepartment of Cogno-Mechatronics Engineering, Pusan National University, Busan 46241, Korea.
Shin-Young ParkDepartment of Dental Education and Dental Research Institute, School of Dentistry, Seoul National University, Seoul 03080, Korea.
Dong-Wook HanDepartment of Cogno-Mechatronics Engineering, Pusan National University, Busan 46241, Korea.ORCID 0000-0001-8314-1981
Suck Won HongDepartment of Cogno-Mechatronics Engineering, Pusan National University, Busan 46241, Korea.ORCID 0000-0001-7291-1020

Funding

Korea Medical Devices Industry Association KMDF-PR-20200901-0108National Research Foundation of Korea NRF‑2021R1A5A1032937
6 · The paper itself

Abstract

Recent developments of point-of-care testing (POCT) and in vitro diagnostic medical devices have provided analytical capabilities and reliable diagnostic results for rapid access at or near the patient's location. Nevertheless, the challenges of reliable diagnosis still remain an important factor in actual clinical trials before on-site medical treatment and making clinical decisions. New classes of POCT devices depict precise diagnostic technologies that can detect biomarkers in biofluids such as sweat, tears, saliva or urine. The introduction of a novel molecularly imprinted polymer (MIP) system as an artificial bioreceptor for the POCT devices could be one of the emerging candidates to improve the analytical performance along with physicochemical stability when used in harsh environments. Here, we review the potential availability of MIP-based biorecognition systems as custom artificial receptors with high selectivity and chemical affinity for specific molecules. Further developments to the progress of advanced MIP technology for biomolecule recognition are introduced. Finally, to improve the POCT-based diagnostic system, we summarized the perspectives for high expandability to MIP-based periodontal diagnosis and the future directions of MIP-based biosensors as a wearable format.

Indexed as

Biosensing TechniquesMolecular ImprintingHumansMolecularly Imprinted PolymersPoint-of-Care SystemsPoint-of-Care TestingSweatMolecularly Imprinted Polymersbiomoleculemolecularly imprinted polymeroral diseasepoint-of-care testwearable device

Identifiers

PMID35323406
PMCPMC8946830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.